Pain drug pulled, can cause adverse reactions
The maker of a prescription pain drug that has been on the market for decades has decided to discontinue making the medication.
Health Canada approved the decision, saying in a release that the risk-benefit ratio of the drug no longer supports its use.
The drug is called 282 MEP; it is made by Pendopharm, which stopped sales of the drug on July 30.
Drug safety researcher Dr. David Juurlink says the drug is a combination of Aspirin, codeine, caffeine and meprobamate and was often used for muscle pain.
It was similar to 222s, commonly used over-the-counter pain pills that combine Aspirin, codeine and caffeine, but with 282 MEP the dosages were stronger.
The addition of meprobamate was what tipped the balance on the drug, with Health Canada saying it can cause severe adverse reactions.